EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1
EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1
In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019
This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 április 2024. Database contains 4917 unique substances/entries.
Filter the list
|
CM 26-137
|
406-052-4
|
125078-60-6
|
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
Details | ||
|
203-733-6
|
110-05-4
|
Org. Perox. E; Flam. Liq. 2; Muta. 2 |
Details | |||
|
233-689-3
|
10311-84-9
|
Acute Tox. 2; Acute Tox. 3 |
Details | |||
|
205-016-3
|
131-17-9
|
Acute Tox. 4 |
Details | |||
|
234-454-8
|
12004-35-2
|
Carc. 1A; STOT RE 1; Skin Sens. 1 |
Details | |||
|
-
|
-
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1 |
Details | |||
|
GENIPLEX A
|
401-610-3
|
122012-52-6
|
Acute Tox. 4; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
Details | ||
|
422-670-7
|
150202-11-2
|
Repr. 2; Acute Tox. 3; STOT RE 2 |
Details | |||
|
240-973-0
|
16919-58-7
|
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
239-793-5
|
15699-18-0
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
-
|
74195-78-1
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
231-786-5
|
7727-54-0
|
Ox. Sol. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
237-499-1
|
13820-41-2
|
Acute Tox. 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
215-116-9
|
1303-28-2
|
Carc. 1A; Acute Tox. 3 |
C Carcinogenic (article 57a) |
Details | ||
|
215-481-4
|
1327-53-3
|
Carc. 1A; Acute Tox. 2; Skin Corr. 1B |
C Carcinogenic (article 57a) |
Details | ||
|
206-373-8
|
333-41-5
|
Acute Tox. 4 |
Details | |||
|
206-382-7
|
334-88-3
|
Carc. 1B |
Details | |||
|
200-181-8
|
53-70-3
|
Carc. 1B |
Details | |||
|
205-878-0
|
189-64-0
|
Carc. 1B; Muta. 2 |
Details | |||
|
205-886-4
|
191-30-0
|
Carc. 1B; Muta. 2 |
Details | |||
|
202-327-6
|
94-36-0
|
Org. Perox. B; Eye Irrit. 2; Skin Sens. 1 |
Details | |||
|
ZK RT 1507
|
417-760-8
|
134164-24-2
|
STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
215-125-8
|
1303-86-2
|
Repr. 1B |
R Toxic for reproduction (article 57c) |
Details | ||
|
200-824-2
|
74-95-3
|
Acute Tox. 4 |
Details | |||
|
201-557-4
|
84-74-2
|
Repr. 1B |
R Toxic for reproduction (article 57c) END Endocrine disrupting properties (Article 57(f) - human health) ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
AMINODARONE OXALATE; SR33580A
|
448-700-9
|
500791-70-8
|
STOT RE 2; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
245-152-0
|
22673-19-4
|
Repr. 1B; STOT RE 1 |
R Toxic for reproduction (article 57c) |
Details | ||
|
220-481-2
|
2781-10-4
|
Muta. 2; Repr. 1B; STOT RE 1 |
Details | |||
|
213-928-8
|
1067-33-0
|
Muta. 2; Repr. 1B; STOT RE 1 |
Details | |||
|
211-670-0
|
683-18-1
|
Muta. 2; Repr. 1B; Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Corr. 1B |
R Toxic for reproduction (article 57c) |
Details | ||
|
201-039-8
|
77-58-7
|
Muta. 2; Repr. 1B; STOT RE 1 |
Details | |||
|
DBB
|
401-040-5
|
75113-37-0
|
Repr. 1B; Muta. 2; STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
201-077-5
|
78-04-6
|
Muta. 2; Repr. 1B; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Skin Corr. 1; Eye Dam. 1 |
Details | |||
|
212-449-1
|
818-08-6
|
Muta. 2; Repr. 1B; Acute Tox. 3; STOT RE 1; Skin Irrit. 2; Eye Dam. 1 |
Details | |||
|
217-635-6
|
1918-00-9
|
Acute Tox. 4; Eye Dam. 1 |
Details | |||
|
214-787-5
|
1194-65-6
|
Acute Tox. 4 |
Details | |||
|
202-564-5
|
97-17-6
|
Acute Tox. 4 |
Details | |||
|
214-118-7
|
1085-98-9
|
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
Details | |||
|
204-210-5
|
117-80-6
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
Details | |||
|
SILAN DCS
|
407-180-3
|
770722-36-6
|
Skin Corr. 1A |
Details | ||
|
220-487-5
|
2782-57-2
|
Ox. Sol. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
Details | |||
|
201-207-0
|
79-43-6
|
Skin Corr. 1A |
Details | |||
|
201-199-9
|
79-36-7
|
Skin Corr. 1A |
Details | |||
|
620-404-6
|
7572-29-4
|
Unst. Expl.; Carc. 2; STOT RE 2 |
Details | |||
|
222-583-2
|
3542-36-7
|
Repr. 1B; Acute Tox. 2; STOT RE 1 |
Details | |||
|
200-838-9
|
75-09-2
|
Carc. 2 |
Details | |||
|
202-567-1
|
97-23-4
|
Acute Tox. 4; Eye Irrit. 2 |
Details | |||
|
204-390-5
|
120-36-5
|
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
Details | |||
|
D-2,4-DP; DICHLORPROP-P; DUPLOSAN DP-ACID
|
403-980-1
|
15165-67-0
|
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
200-547-7
|
62-73-7
|
Acute Tox. 2; Acute Tox. 3; Skin Sens. 1 |
Details | |||